Brief: Hansa Biopharma Q1 Net Income SEK -196.3 Million
23/04/2026 06:01
Apr 23 (Reuters) - Hansa Biopharma Q1 cash & investments SEK 676.5 million. Q1 EBIT SEK -142.5 million Q1 revenue SEK 34.6 million Q1 adjusted EPS SEK -1.93
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS